SLC1A1 (EAAT3 / EAAC1) — curation notes
UniProt: P43005 (EAA3_HUMAN), 524 aa. HGNC:10939. Chromosome 9p24.2.
Family: dicarboxylate/amino acid:cation symporter (DAACS, TC 2.A.23), SLC1A1 subfamily;
PANTHER PTHR11958:SF109. Mouse ortholog P51906, rat P51907, bovine Q95135 (all EAAT3/Slc1a1).
Core biology (synthesized)
SLC1A1/EAAT3 is a sodium-dependent, high-affinity transporter of acidic amino acids
(L-glutamate, L-aspartate, D-aspartate) that also transports L-cysteine. It is a
secondary active transporter that couples uptake of one amino acid to symport of 3 Na+
and 1 H+ and counter-transport (antiport) of 1 K+, and additionally carries a
thermodynamically uncoupled anion (Cl-) conductance.
- Coupling stoichiometry established by flux measurements: PMID:8857541. Supports a transmembrane glutamate gradient >10^6.
- High affinity, electrogenic, plasma-membrane transport: PMID:7914198; Km L-glutamate ~30 µM (Kanai), 18–97 µM across assays (Arriza PMID:7521911).
- Substrate range (UniProt FUNCTION): [file:human/SLC1A1/SLC1A1-uniprot.txt "Sodium-dependent, high-affinity amino acid transporter that mediates the uptake of L-glutamate and also L-aspartate and D-aspartate"]; [file:human/SLC1A1/SLC1A1-uniprot.txt "Can also transport L-cysteine"].
- Uncoupled chloride flux: [file:human/SLC1A1/SLC1A1-uniprot.txt "Mediates Cl(-) flux that is not coupled to amino acid transport; this avoids the accumulation of negative charges due to aspartate and Na(+) symport"]. This is a substrate-gated anion channel property of EAATs, not a coupled transport step; genuine but non-core.
- Structure: homotrimer, elevator mechanism; cryo-EM of hEAAT3 with Na+/aspartate PMID:33658209. UniProt SUBUNIT: [file:human/SLC1A1/SLC1A1-uniprot.txt "Homotrimer"].
Physiological roles
- Epithelial (kidney/intestine) reabsorption of glutamate/aspartate — the dominant role in humans:
- PMID:21123949; apical proximal tubule: PMID:21123949.
- PMID:33658209.
- Loss of function → dicarboxylic aminoaciduria (DCBXA, MIM:222730), autosomal recessive; variants R445W and I395del PMID:21123949.
- Neuronal: somatodendritic glutamate transporter; buffers synaptic/perisynaptic glutamate (minor vs EAAT2). Immunolocalization: PMID:9409715; glia-negative: PMID:9409715. Excluded from presynaptic membranes: PMID:33658209.
- Neuronal cysteine uptake → glutathione / antioxidant defense: EAAT3 is the major neuronal Na+-dependent cysteine route: PMID:21123949; PMID:33658209. NOTE: EAAT3 supplies the cysteine substrate; it does not itself catalyse any glutathione-biosynthesis step (GCL/GSS do). So GO:0006750 glutathione biosynthetic process is a substrate-supply/upstream role, not participation → over-annotation. Likewise superoxide metabolic process, neuron apoptosis protection are downstream of transport.
Regulation / interactions
- ARL6IP5 / GTRAP3-18 (JWA): negative modulator of EAAT3 glutamate uptake PMID:12562531. UniProt: "Negatively regulated by ARL6IP5."
- Caveolin-1: negative regulator, forms complexes with EAAT3 PMID:26690923.
- Numb: clathrin adaptor directing EAAT3 trafficking via YVNGGF (YxNxxF) motif PMID:27358480; EAAT3 "localizes primarily within the cell and at the apical plasma membrane" — intracellular recycling-endosome pool.
- Many PDZ scaffolds (DLG1-4/PSD-95, GRIP1/2, PDZK1, NHERF2/4, MPDZ, MAGI1/2, PATJ, TJP1, WHRN) and RNF5, RTN2, SORCS2 (UniProt SUBUNIT/INTERACTION). These are captured as regulation/trafficking context; bare GO:0005515 protein-binding rows are uninformative and removed per policy.
Disease
- DCBXA (MIM:222730) — the established LoF phenotype PMID:21123949.
- SCZD18 susceptibility (MIM:615232) — 9p24.2 deletion upstream of SLC1A1 [UniProt DISEASE; PMID:21982423, PMID:23341099]. Regulatory/dosage, not a transporter-function claim.
Localization summary
Core: plasma membrane (GO:0005886), apical plasma membrane in epithelia (GO:0016324).
Non-core (genuine but peripheral): somatodendritic/synaptic neuronal compartments (soma,
dendrite/spine/shaft, perikaryon, axon terminus, synapse, perisynaptic), endosomal
recycling pool (early/late/recycling endosome membrane), membrane raft/caveolae,
cell surface, urinary extracellular exosome (HDA, PMID:19056867).
"Active in cytoplasm" is misleading (the transport activity is at the PM).
Glial cell projection ISS is at odds with the neuronal/epithelial expression and
Shashidharan's astrocyte-negative data → over-annotation (ortholog transfer).
Annotation decisions (headline)
- Core MF: high-affinity L-glutamate transmembrane transporter activity (GO:0005314),
glutamate:sodium symporter activity (GO:0015501), L-aspartate transmembrane transporter
activity (GO:0015183), L-cysteine transmembrane transporter activity (GO:0033229).
- TOO_GENERAL: symporter activity (GO:0015293), amino acid transport (GO:0006865),
import into cell (GO:0098657), cell periphery (GO:0071944) — all entailed by accepted specifics.
- MODIFY membrane (GO:0016020) → plasma membrane (GO:0005886).
- REMOVE: all bare protein binding (GO:0005515) rows (IntAct/IPI + MGI) per protein-binding policy.
- MARK_AS_OVER_ANNOTATED: Ensembl ortholog-projected behavioral/pharmacological/physiological
phenotypes (response to amphetamine/morphine/cocaine, grooming/locomotory/motor/adult/exploration
behavior, memory, conditioned place preference, heart-rate regulation, dopamine signaling/metabolism,
gene expression, cytokine signaling, neurogenesis, brain/retina development, synapse organization,
glutamate receptor signaling, neuron apoptosis +/- reg); downstream metabolic terms (glutathione
biosynthetic process, superoxide metabolic process, zinc homeostasis/transport); BBB terms
(transport across/maintenance of BBB, blood vessel morphogenesis); is_active_in cytoplasm;
glial cell projection; presynapse.